Holen Sie sich die Stockscreener-App
4.49
7.16%
0.30
Handel nachbörslich:
4.54
0.05
+1.11%
Schlusskurs vom Vortag:
$4.19
Offen:
$4.12
24-Stunden-Volumen:
1.46M
Relative Volume:
0.80
Marktkapitalisierung:
$713.72M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
-0.7434
EPS:
-6.04
Netto-Cashflow:
$146.36M
1W Leistung:
+5.65%
1M Leistung:
+4.42%
6M Leistung:
-44.70%
1J Leistung:
-52.74%
1-Tages-Spanne:
$4.06
$4.51
1-Wochen-Bereich:
$3.93
$4.51
52-Wochen-Spanne:
$3.79
$15.70
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Firmenname
Ironwood Pharmaceuticals Inc
Sektor
Telefon
617-621-7722
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-17 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-09 | Eingeleitet | Jefferies | Buy |
| 2023-09-28 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2022-09-02 | Eingeleitet | CapitalOne | Overweight |
| 2022-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-30 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Eingeleitet | Northland Capital | Outperform |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-03-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Hochstufung | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Sell |
| 2018-05-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2017-07-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Eingeleitet | Wells Fargo | Outperform |
| 2017-04-07 | Bestätigt | Mizuho | Buy |
| 2017-02-22 | Bestätigt | Barclays | Equal Weight |
| 2016-11-04 | Bestätigt | Mizuho | Buy |
| 2016-10-24 | Bestätigt | Wedbush | Neutral |
| 2016-10-10 | Bestätigt | Mizuho | Buy |
| 2016-09-27 | Bestätigt | WallachBeth | Hold |
Alle ansehen
Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten
Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Emerald Mutual Fund Advisers Trust Sells 446,757 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine
Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat
What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register
Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat
Ironwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease Study - MarketWatch
Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2 - Business Wire
Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World
Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call - Business Wire
Lacklustre Performance Is Driving Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Low P/S - Simply Wall St
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8%What's Next? - MarketBeat
Exchange Traded Concepts LLC Takes Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Financial Survey: Regulus Therapeutics (NASDAQ:RGLS) & Ironwood Pharmaceuticals (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Zacks Research Has Negative Outlook for IRWD FY2025 Earnings - Defense World
Zacks Research Research Analysts Decrease Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Zacks Research Analysts Lower Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Wedge Capital Management L L P NC Purchases Shares of 314,843 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
The Manufacturers Life Insurance Company Trims Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
State Street Corp's Strategic Acquisition of Ironwood Pharmaceuticals Shares - Yahoo Finance
Is Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts? - Insider Monkey
Q1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by Analyst - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.1%What's Next? - MarketBeat
Leerink Partners gives a Market perform recommendation for Ironwood Pharmaceuticals Inc (IRWD) - Knox Daily
Financial Metrics Exploration: Understanding Ironwood Pharmaceuticals Inc (IRWD) Through Ratios - The Dwinnex
Ironwood Pharmaceuticals Inc (IRWD) did well last session? - US Post News
14,200 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Algert Global LLC - Defense World
Irritable Bowel Syndrome Treatment Market is Booming with - openPR
Insider Selling: John Minardo, Ironwood Pharmaceuticals Inc [IRWD] Chief Legal Officer divested 9,910 shares - Knox Daily
How to interpret Ironwood Pharmaceuticals Inc (IRWD)’s stock chart patterns - US Post News
Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... By GuruFocus - Investing.com Canada
Ironwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ... - Yahoo Finance
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 3.6% HigherShould You Buy? - MarketBeat
Bank of Montreal Can Sells 8,419,683 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ratio Analysis: Unpacking Ironwood Pharmaceuticals Inc (IRWD)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Taking a Closer Look At Ironwood Pharmaceuticals Inc (IRWD) Following Its Recent Trade - Knox Daily
8 Penny Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Squarepoint Ops LLC Has $688,000 Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 6.7%Should You Sell? - MarketBeat
An analyst sees good growth prospects for Ironwood Pharmaceuticals Inc (IRWD) - SETE News
Marshall Wace LLP Has $1.42 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
American Century Companies Inc. Trims Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
American Century Companies Inc. Cuts Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat
Axa S.A. Decreases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World
Ironwood Pharmaceuticals Inc (IRWD) Stock: A Year of Market Fluctuations - The InvestChronicle
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6% - Defense World
Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 6% Higher - MarketBeat
Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Silver Ronald | Principal Accounting Officer |
Aug 12 '24 |
Sale |
4.27 |
3,107 |
13,267 |
158,370 |
0.88%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):